z-logo
Premium
ASTHMA SYMPTOM IMPROVEMENTS WITH BENRALIZUMAB ARE ASSOCIATED WITH IMPROVEMENTS IN ACTIVITY FUNCTIONS AND QUALITY OF LIFE FOR PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA
Publication year - 2017
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13207_218
Subject(s) - medicine , asthma , benralizumab , citation , quality of life (healthcare) , family medicine , library science , nursing , mepolizumab , eosinophil , computer science

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom